CompanyDrug

Cutia Therapeutics Achieves Primary Endpoint in Phase I Study of CU-40101 for Androgenic Alopecia

CompanyDeals

Sanofi Regains Exclusive Rights to Rezurock in China, Terminating Agreement with BioNova and BK Pharmaceuticals

CompanyDrug

Innovent Biologics Reports Q3 2023 Sales Exceeding RMB 1.6 Billion with 45% YOY Growth

CompanyMedical Device

Amoy Diagnostics Receives NMPA Approval for MSI Detection Kit as Companion Diagnostic for Immunotherapy

CompanyDrug

Gaush Meditech Ltd Receives NMPA Approval for Rigid Corneal Contact Lens

CompanyDrug

Wuhan Hiteck Biological Pharma Receives NMPA Approval for Aponermin in Multiple Myeloma Treatment

CompanyDrug

Abbisko Therapeutics to Present CSF-1R Inhibitor ABSK021 Data at CTOS Annual Meeting

CompanyDrug

Ascentage Pharma’s Olverembatinib Showcases Promising Results at ASH Annual Meeting

CompanyMedical Device

Sino Medical Sciences Technology Secures TFDA Approval for HT Supreme Drug-Eluting Stent System

CompanyDrug

Shanghai Pharmaceuticals Gets NMPA Approval for Phase I Clinical Study of B019 CAR-T Cell Injection

CompanyDrug

I-Mab and HI-Bio’s Felzartamab Earns Breakthrough Therapy Designation from US FDA

Company

Eli Lilly & Co. Reports 36% YOY Sales Growth in Q3 2023 with Key Drug Performances